Join
Live feed
·
INSIDERFilingvia Quantisnow
Vir Biotechnology Inc. logo

Chief Executive Officer De Backer Marianne was granted 240,000 shares and sold $152,408 worth of shares (16,122 units at $9.45), increasing direct ownership by 36% to 849,217 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIR (Vir Biotechnology Inc.) and more on Quantisnow.